News | Stroke | February 09, 2023

Imperative Care Announces Formation of Stroke Recovery Digital Health Company Kandu Health

Internationally renowned stroke treatment expert Dr. Tudor Jovin joins Kandu Health as Chief Medical Officer

Tudor Jovin, MD

Tudor Jovin, MD 


February 9, 2023 — Imperative Care, a medical technology company developing connected innovations to elevate care for people affected by vascular diseases, today announced the formation of Kandu Health, a digital health startup company with the aim of changing the course of stroke recovery and post-acute care. 

The company also announced that Tudor Jovin, M.D., an internationally renowned researcher and practitioner in the treatment of stroke and other cerebrovascular disorders, has joined Kandu Health as its Chief Medical Officer. Dr. Jovin serves as Medical Director of the Cooper Neurological Institute, and Chairman and Chief of Neurology at Cooper University Health Care in Camden, New Jersey. He is also a Professor of Neurology and Neurological Surgery at Rowan University’s Cooper Medical School

“The formation of Kandu Health as an independent company will allow us to scale our programs to bring critical support to people affected by stroke,” said Kirsten Carroll, Kandu Health’s General Manager. “We are honored to have Dr. Jovin’s expertise and guidance. With the support of our team of stroke survivors and healthcare professionals, Kandu Health is empowering stroke survivors to take charge of their recovery and achieve their best life after stroke.” 

“Our commitment to transforming the full continuum of care for people affected by stroke and other vascular conditions is rooted in the reality that the challenges for these patients do not end when they leave the hospital. Our strategy at Imperative Care has been to foster connected innovations across multiple development programs that can, in turn, connect care across the entire patient journey,” said Fred Khosravi, Imperative Care’s Chairman and CEO. “Through this formation as an independent company, Kandu Health will focus on its digital health platform and scale its critical patient solutions rapidly.” 

In the United States, 800,000 people have a stroke each year1. Historically, most investment in stroke care has focused on acute intervention. While most people who have a stroke survive, they usually return home with changed bodies, minds, and lives. Research indicates that in the first three months after a stroke, the average survivor needs nearly 50 hours a week2 of informal care. Post-acute clinical care in the first year after stroke is estimated to cost $20 billion annually, primarily driven by a one-year re-hospitalization rate of about 50% from events like recurrent stroke, infections and falls. 3 

Kandu Health offers remote clinical support from Kandu Navigators who are licensed healthcare professionals who provide education, resources and guidance, tailored to each participant. Kandu educational content and clinical programming is developed in collaboration between stroke survivors, care partners, and clinicians representing over 10 disciplines of medicine. Kandu’s services are primarily delivered through Kandu’s app and further supplemented by in-app tools and support groups. Kandu Health works closely with client healthcare institutions to ensure that care is well integrated and coordinated with existing programming. 

“The Kandu platform serves as a bridge for stroke survivors, guiding them along their care plan and beyond after leaving the hospital,” said Dr. Jovin. “It also gives the survivor’s healthcare team new visibility and insights into the quality of life and long-term outcomes for patients who have returned home. Our hope is that this combination of technology and human care will decrease secondary events and help survivors maximize their potential for prevention and recovery after stroke.” 

For more information: https://imperativecare.com 


Related Content

News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
News | Heart Failure

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the ...

Home March 25, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions ...

Home March 15, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc., a biotechnology company focused on advancing late-stage cell therapy interventions for ...

Home March 15, 2024
Home
News | Heart Failure

March 13, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2024
Home
News | Heart Failure

March 8, 2024 — The Texas Heart Institute, Georgia Institute of Technology (Georgia Tech), North Carolina State ...

Home March 08, 2024
Home
News | Heart Failure

March 5, 2024 — FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2 ...

Home March 05, 2024
Home
Subscribe Now